-
News
iStockphoto
Researchers Try to Solve the Mystery of HIV Carriers Who Don't Contract AIDS
More than half a million people in the U.S. have died from HIV infection , and more than a million currently live with the virus, but a relative handful of people infected with HIV never get treatment for it and never get sick from it.
-
EarthTalk
Bumping Off Bedbugs without Poison
Although increased worldwide travel and the rising popularity of second-hand goods may contribute to bedbugs' resurgence, the most likely reason is the rejection of DDT and other harsh chlorinated hydrocarbon insecticides -
News
Renewed Hope for an AIDS Vaccine
Despite questions, the Thailand trial spreads optimism -
Features
Squashing Malaria: Advances in Research and Prevention [Slide Show]
From satellites to bacteria, researchers are searching high and low for the best tools to eradicate malaria -
News
Out of Africa: The Tobacco War's New Battleground
As nicotine use spreads across Africa, cancer-fighting groups are advocating for stringent smoke-free laws as tobacco companies lobby to expand in a growing continental market
The Color of Sin--Why the Good Guys Wear White
An Elemental Solution: Using Zinc to Stave Off Childhood Diarrhea in Developing Countries
How Threatened Are Killer Whales in the Wild?
Obama lifts U.S. ban on foreign HIV-positive travelers
Zombie Creatures: What Happens When Animals Are Possessed by a Parasitic Puppet Master? [Slide Show]
Sick-clop: Ponies with the flu show how virus out-mutates vaccines
Global Child Immunizations at All-Time High, Despite Rising Costs
Rare Frog Species Bear the Brunt of Chytrid, a Deadly Fungal Disease
When the Economy Is in the Red, Are People Really in the Pink?
Is an HPV vaccine for boys cost-effective?
Researchers Try to Solve the Mystery of HIV Carriers Who Don't Contract AIDS
Zombie Creatures: What Happens When Animals Are Possessed by a Parasitic Puppet Master? [Slide Show]
Renewed Hope for an AIDS Vaccine
Bumping Off Bedbugs without Poison
Retrovirus Linked to Chronic Fatigue Syndrome, Could Aid in Diagnosis
Does Inflammation Trigger Insulin Resistance and Diabetes?
Squashing Malaria: Advances in Research and Prevention [Slide Show]
Pandemic Payoff from 1918: A Weaker H1N1 Flu Today
Readers Respond on "What Now for Nuclear Waste?"
AIDS vaccine surprises scientists, proves partially successful
The Color of Sin--Why the Good Guys Wear White
Scientific American Magazine
December 2009 Issue
Does Inflammation Trigger Insulin Resistance and Diabetes?
Conditional Consciousness: Predicting Recovery from the Vegetative State
Crack Research: Good news about knuckle cracking.
The Double Life of ATP in Humans
Piercing the Plasma: Ideas to Beat the Communications Blackout of Reentry
Full Table of Contents | All IssuesInfectious Diseases Podcast
-
Less Fungus among Us Warm-Blooded
click to enable
-
Celeb Vaccine Wars: Peet Beats Maher
click to enable
- Subscribe: RSS · iTunes · All Podcasts
Discussions in Infectious Diseases
- Most Commented
Out of Africa: The Tobacco War's New Battleground | 18 comments - Most Recent Comment
at 11:01 PM by whatamidoinghere on
Is an HPV vaccine for boys cost-effective?
ALL SLIDESHOWS Infectious Diseases Slideshows
ALL VIDEO Infectious Diseases Videos
Infectious Diseases News from Our Partners
- Nature HIV vaccine trial under fire
Infectious Diseases Archive
Subscription Center
Health & Medicine Newsletter
Get weekly coverage delivered to your inboxMORE TOPICSExplore Health & Medicine
Editor's Pick
-
Adapting to the Freshwater CrisisForward-thinking experts are getting a better handle on the growing global water shortage and coming up with innovative approaches to ensuring the security, safety and sustainability of this resource
Latest Stories on ScientificAmerican.com
Extinction Countdown
Fight to protect California condors from lead ammunition moves to Arizona
News
Circulation of LHC Beams Could Resume in Earnest over the Weekend
Features
Measuring Up: New NIST Director, Plus Big Budget Put Measurement Science in Public Eye
News
How Long Can a Nuclear Reactor Last?
Features
What to Do About Endocrine Disruptors? A Q&A with Linda Birnbaum